Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans.

類似資料

• Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
  著者:: Richardson, K, 等
  出版事項: (1985)
• Fluconazole (UK-49,858) treatment of candidiasis in normal and diabetic rats.
  著者:: Fisher, M A, 等
  出版事項: (1989)
• Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
  著者:: Troke, P F, 等
  出版事項: (1985)
• Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum.
  著者:: Kobayashi, G S, 等
  出版事項: (1986)
• Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.
  著者:: Rogers, T E, 等
  出版事項: (1986)